US · Healthcare · Biotechnology
EPS came in at -0.21 against a street estimate of -0.24 — a beat of 12.5%.
Analysts rate Alector Inc a hold (3 buy, 2 hold, 2 sell out of 7) with an average price target of $3.90.
| Fund | Stake |
|---|---|
| TCG Crossover Management, LLC | 8.96% |
| Nantahala Capital Management, LLC | 7.73% |
| BlackRock Inc | 7.03% |
| Acadian Asset Management LLC | 3.95% |
| Vanguard Capital Management, LLC | 3.59% |
| Kynam Capital Management, LP | 3.41% |
| Merck & Co Inc | 3.18% |
| Balyasny Asset Management LLC | 2.91% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Alector Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.